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Terminal Schwann cells (TSCs) that cover motor neuron terminals, are known to play an
important role in maintaining neuromuscular junctions, as well as in the repair process after
nerve injury. However, the molecular characteristics of TSCs remain unknown, because of
the difficulties in analyzing them due to their paucity. By using our previously reported
method of selectively and efficiently collecting TSCs, we have analyzed the difference in
expression patterns of lysophospholipid (LPL) receptor genes (LPA1,  LPA2,  LPA3,  S1P1,
S1P2, S1P3, S1P4, and S1P5) between TSCs and myelinating Schwann cells (MSCs). LPL,
which includes lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), is the
bioactive lipid that induces a myriad of cellular responses through specific members of G-
protein coupled receptors for LPA. It turned out that LPA3 was expressed only in TSCs,
whereas S1P1 was expressed in TSCs and skeletal muscle, but not in MSCs. Other types
of LPL receptor genes, including LPA1, S1P2, S1P3, S1P4, were expressed in both types of
Schwann cells. None of the LPL receptor gene family showed MSCs-specific expression.
Key words: terminal Schwann cell, myelinating Schwann cell, lysophospholipid receptors, single 
cell RT-PCR, in situ hybridization
I. Introduction
Lysophospholipid (LPL) is a phospholipid signaling
molecule and its functions that have been reported up to now
include cell proliferation, myogenesis, stress fiber forma-
tion, neurite retraction and transient increase of Ca2 [1, 2,
7]. The effects of LPL are mediated through distinct G-pro-
tein coupled receptors that are encoded by a different gene
family. The first lysophosphatidic acid (LPA) receptor gene
identified was the “ventricular zone gene-1 (vzg-1/LPA1)”,
which was abundantly expressed in the ventricular zone of
the embryonic cerebral cortex [3]. Recent studies demon-
strated that LPA is related to the up-regulation of myelin-
specific protein, morphological changes, and survival of
Schwann cells (SCs) [22, 24]. Especially, Weiner and Chun
demonstrated that LPA1 was expressed by postnatal SCs, and
that LPA promotes SC survival via LPA1 activation and a
pathway including Gi, PI3K (phosphoinositide-3-kinase)
and Akt [23].
In the peripheral nervous system, SCs play important
roles in the axonal regeneration following nerve injury. It is
well known that there are two types of SCs, myelinating
Schwann cells (MSCs) and terminal Schwann cells (TSCs).
TSCs are located at neuromuscular junctions (NMJs) and the
number of TSCs is usually 2–6 cells at individual NMJs
[15]. Following partial denervation, processes of TSCs
extend to the neighboring NMJ and induce the axonal regen-
eration from the neighboring NMJ [16–18]. On the other
hand, MSCs extend, migrate, and proliferate in the same
axonal tube after nerve injury [19, 20]. These differences in
post-injury reaction between TSCs and MSCs may reflect
the physiological significance of each type of SCs. How-
ever, the analysis of TSCs is difficult due to the paucity
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and the intricacy of collecting TSCs. We have previously
devised a novel method of obtaining TSCs at the single
cell level and found a TSC-specific gene, Herp, by applying
PCR-differential display [13].
In order to elucidate the molecular characteristics of
TSCs when compared to MSCs, we have studied the expres-
sions of LPL receptors by single cell RT-PCR and in situ
hybridization.
II. Materials and Methods
Animals
Adult Wistar rats (9- to 10-week-old female) were
purchased from a breeder (SLC, Japan) 4 days prior to
treatment, and maintained in a temperature- and humidity-
controlled animal facility with a 12:12-hr light:dark cycle.
The studies were approved by the Kyoto Prefectural Uni-
versity of Medicine Institutional Animal Care and Use Com-
mittee and all the experiments were carried out in full com-
pliance with the Rules and Regulations for the Experimental
Use and Care of Laboratory Animals at Kyoto Prefectural
University of Medicine.
Preparation of total RNA from skeletal muscle and Schwann 
cells, and of genomic DNA
Total RNAs from soleus muscle and kidney were
extracted and purified with RNeasy Mini kit (Qiagen, USA)
according to the manufacturer’s instruction. Total RNAs
from terminal Schwann cells and myelinating Schwann cells
were prepared as previously described [13]. Briefly, single
terminal Schwann cell was isolated as follows. The soleus
muscle was dissected out from the animals after deep anes-
thesia by intraperitoneal injection of sodium pentobarbital.
The muscle was trimmed in a central portion at the entry
point of the sciatic nerve branch and embedded in a low-
melting temperature agarose gel. Cross sections, 500 m in
thickness, of the muscle were prepared with a microslicer.
The sections that include the nerve branch were selected for
further studies. NMJs were stained with a fluorescent dye, 4-
(4-diethylaminostyryl)-N-methyl-pyridinium iodide (4-Di-
2-ASP, Molecular Probes, USA). After enzymatic treatment
for cell dissociation, individual cells were collected careful-
ly with microcapillaries under an epifluorescent stereo-
microscope (Nikon, Japan) and transferred into small tubes
containing the cell lysis buffer in Strataprep total RNA
microprep kit. Myelinating Schwann cells were prepared
from the sciatic nerves of adult Wistar rats. Sciatic nerves,
free of perineurium and epineurium, were incubated with
collagenase and trypsin to obtain dissociated cells. The cells
were collected and transferred into the lysis buffer by using
microcapillaries under conventional phase contrast micro-
scope. After adding yeast tRNA (50 ng) to the above cell
lysates, total RNA from each single cell was purified accord-
ing to the instruction manual in the kit. Genomic DNA from
kidney was purified with DNeasy tissue kit (Qiagen, USA)
according to the manufacturer’s instruction.
cDNA synthesis
Total cDNAs from each type of single cell were syn-
thesized and amplified using SMART cDNA synthesis kit
(Clontech, USA) as previously described [4, 14]. The opti-
mized number of thermal cycling was set at 18. Under these
conditions, each amplified total cDNA fraction was obtained
as moderately strong smears ranging from 0.2 to 4.0 kb
with a scattering of several bright bands. Gene expression of
Herp (a marker of terminal Schwann cell), S-100, and
GAPDH in each cDNA fraction was confirmed by PCR.
First strand cDNAs from soleus muscle and kidney
were reverse-transcribed from 5 g of DNase I-treated total
RNA using random hexamers and Superscript II RNase H
(Invitrogen, USA).
PCR amplification of the genes of LPL receptor family from 
the cDNAs and genomic DNA
PCR using the amplified cDNAs, the first strand
cDNA, and the genomic DNA as templates, was carried out
with ExTaq DNA polymerase (TaKaRa Bio, Japan).
For the PCR reactions, sets of primers corresponding to
each gene of LPA receptor family were used: 5'-CACTAA-
CCAATGGCAGTATTTGTC-3' and 5'-CTGGCTTAGGC-
CAAACCACATAA-3' (LPA1), 5'-AGCCTGCTTGTCTTC-
CTRCTCAT-3' and 5'-TAAAGGGTGGAGTCCATCAG-3'
(LPA2), 5'-TACATGCTACACACACGGGTGTA-3' and 5'-
TAGCGATCTCCTCATGCTCGTA-3' (LPA3), 5'-GCCTA-
AGGACTATGCTGCTGTAA-3'  and 5'-GAGTGTGACC-
AAGGACAGTCATA-3' (S1P1), 5'-CGGAGGCACTGAC-
TAATCAGATT-3' and 5'-TCCCAGCACTCAGGACACA-
GTTA-3' (S1P2), 5'-AACCACAACTCCGAGAGATCCAT-3'
and 5'-TTGAAGAGGATGGAGCACTCCTT-3' (S1P3), 5'-
TRCTSAASACSGTGCTGATGAT-3' and 5'-CKGCTGC-
GGAAGGAGTAGATGA-3' (RA/G, KG/T:  S1P4), 5'-
CGTGTCCTGTGCTTCTGCAA-3' and 5'-CTGCAAACT-
GTTGGAGGAGTCTT-3' (S1P5).
Each PCR products were size-fractionated with 2%
agarose gel electrophoresis followed by visualization with
ethidium bromide. 2-log Ladder DNA size marker (New
England BioLab, USA) was used as a size marker.
Sequencing
PCR products were cloned into pCRII TOPO plasmid
DNA (Invitrogen, USA). Nucleotide sequence of each
product was determined using Big Dye terminator cycle
sequencing kit (v1.1) (Applied Biosystems, USA) and
PRIZM310 Genetic Analyzer (Applied Biosystems, USA).
Homology search was performed with BLAST 2.0 software
program for the databases of GenBank, EMBL, DDBJ, and
PDB.
In situ hybridization
Animals were deeply anesthetized with sodium pento-
barbital and were transcardially perfused with 4% paraform-
aldehyde in phosphate buffered saline. Soleus muscles were
dissected out and embedded in a low-melting temperature
agarose gel. Longitudinal sections of the muscle, 200 mLPL Receptors in Rat Terminal Schwann Cells 57
thick, were prepared with a microslicer.
The PCR-amplified cDNA fragment of rat LPA3 (nt
1661–2111, GenBank NM_023969) was cloned into pGEM-
T Easy plasmid DNA (Promega, USA). Digoxigenin-
labeled cRNA probes were obtained by in vitro transcription
using the plasmid as template. Sense- and antisense-strand
probes were synthesized using SP6- and T7 RNA poly-
merase (Roche Diagnostics, Switzerland), respectively.
In situ hybridization was carried out according to the
whole mount in situ hybridization protocol as described
elsewhere [5, 13] using alkaline phosphatase-labeled anti-
DIG antibody (Fab)2 fragment (Roche Diagnostics, Switzer-
land) and NBT/BCIP.
III. Results
In order to study whether each member of LPL receptor
family is expressed in a cell-type-specific manner, we have
analyzed the total cDNAs prepared from TSCs, MSCs and
skeletal muscle, respectively, by PCR amplification with
each gene-specific primer.
For this purpose, we collected each type of Schwann
cells and purified their total RNAs followed by first strand
cDNA synthesis and PCR amplification of total cDNAs. As
shown in Figure 1A, we obtained total cDNAs fractions
from each type of Schwann cell. Some of the amplified
cDNAs fractions were insufficient (such as T1 in Fig. 1A).
Such total cDNAs fractions were not used for the following
analysis. Then, the expression of three genes, including
Herp (a marker of terminal Schwann cell, as demonstrated in
[13]), S-100 (a marker of Schwann cell) and GAPDH (a
housekeeping gene) in each cDNA fractions was confirmed
by PCR (as shown in Fig. 1B). The total cDNAs fractions
expressing three genes mentioned above were used for
analyzing the expression of LPL receptor mRNAs.
We compared the pattern of mRNA expression of LPL
receptor family genes between terminal Schwann cells and
myelinating Schwann cells. PCR reactions were carried out
Fig. 1. (A) Representative results of the size distribution of total cDNAs amplified from terminal Schwann cells and myelinating Schwann cells.
T1 is of a failure in amplification for total cDNAs from terminal Schwann cells. T2 shows a successful amplification for total cDNAs from ter-
minal Schwann cells. () denotes reverse transcriptase-omitted reaction as a negative control. (B) cDNA amplification of GAPDH, S100 and
Herp from each single cell-derived total cDNA fraction. (C) Comparison of each LPL receptor mRNA expression among TSCs, MSCs and skel-
etal muscles, using each gene-specific primer set. RTase() indicates negative controls: results of amplification using each gene-specific primer
set and reverse transcriptase-omitted total cDNAs fraction. Mr, DNA size marker; T, terminal Schwann cells; M, myelinating Schwann cells;
S, skeletal muscles; K, kidney; g, rat kidney genomic DNA.Kobashi et al. 58
using each set of the family member gene-specific primers
and the total cDNAs prepared as described above. Amplifi-
cation target sequence of each gene except for LPA2 was
included within a single exon of each gene. Rat genomic
DNA, therefore, was used as a positive control template for
each PCR reaction. For LPA2, however, rat kidney cDNAs
were used as a positive control. Because each primer for
LPA2 is located in different exons of the gene, the amplifica-
tion condition of PCR conducted for cDNA template was
not applicable to genomic DNA template. Hence, cDNAs
from adult rat kidney where LPA2 mRNA is known to be
expressed was used as the positive control template. On the
other hand, reverse transcriptase-omitted reaction product as
shown in Fig. 1A) was used as a negative control template.
As shown in Figure 1C, LPA3 was expressed only in
TSCs, whereas S1P1 was expressed in TSCs and skeletal
muscle, but not in MSCs. Neither LPA2 nor S1P5 was detect-
able in either type of Schwann cell. Other types of LPL
receptor genes, including LPA1, S1P2, S1P3, and S1P4, were
expressed in both types of Schwann cells. None of the LPL
receptor family genes showed MSC-specific expression.
To confirm whether LPA3 was expressed selectively in
TSCs, we have performed in situ hybridization in NMJs of
adult rat soleus. In situ hybridization was carried out for the
longitudinal sections of adult rat soleus muscle, according to
a whole mount in situ hybridization protocol. With antisense
probe, strong signals were detected specifically in the cell
bodies located on top of motor nerve terminals, but not in
nerve terminals themselves, axons, or postsynaptic areas
(Fig. 2B, C). No signal was detected using sense probe as a
negative control (Fig. 2A).
IV. Discussion
The present study demonstrated the specific expression
of LPA3 in TSCs present in NMJs of adult rat soleus, with
single-cell based RT-PCR as well as in situ hybridization.
We have also demonstrated by RT-PCR that none of the
LPL receptor family genes showed MSCs-specific expres-
sion.
In the peripheral nervous system, there are two types of
Schwann cells, TSCs and MSCs. Both types of Schwann
Fig. 2. In situ hybridization in adult rat soleus using LPA3 sense cRNA probe as a negative control (A) and LPA3 antisense cRNA probe (B–D).
Cell bodies of terminal Schwann cells on the rat soleus were stained (black arrowheads in B, C, D). Unstained axons were visualized under a dif-
ferential interference contrast microscope (black arrows). D is a higher magnification image of the area indicated by a rectangle in C. Longitudi-
nal and horizontal stripes were muscle fibers. Bar50 m (A), 20 m (B), 40 m (C), and 10 m (D).LPL Receptors in Rat Terminal Schwann Cells 59
cells share the same lineage of cell origin, that is, neural
crest cells, but behave in a different manner after maturation
[8]. MSCs are known to contribute to axonal outgrowth and
guidance in the regeneration process following nerve injury
[6, 19]. On the other hand, TSCs appear to play pivotal roles
in maintaining the structure and function of NMJs as well as
in the repair process [6, 21]. Recently, Son and Thompson
and Son et al. demonstrated that processes of TSCs extend to
the neighboring NMJ following partial denervation and the
axonal regeneration was observed along the processes of
TSCs [16, 18]. The mode of nerve sprouting at NMJ is dif-
ferent from that at the nodes of Ranvier following injury.
The regenerating sprouts which emerge from the nodes of
Ranvier always extend distally within the basal lamina of
MSCs [14]. On the other hand, the terminal nerve sprouts
penetrate their own Schwann cell basal lamina tubes and
grow toward the neighboring NMJ [17]. These different
modes of nerve sprouting may reflect different properties of
Schwann cell resources, i.e., TSCs and MSCs. However,
there are few studies on the comparative aspects of physio-
logical as well as pathological characteristics of TSCs and
MSCs. We previously devised a method of isolating and col-
lecting TSCs [13] and this method enabled us to analyze
gene expression in TSCs by RT-PCR. Here, we have applied
a similar method to elucidate the expression of LPL receptor
family genes in TSCs and compared the expression between
TSCs and MSCs.
LPL is a phospholipid signaling molecule that has
intercellular signaling pathways and has the broad biological
functions such as cell proliferation, myogenesis, stress fiber
formation, neurite retraction and increase of Ca2 [9–12].
The LPL receptor family of G-protein coupled receptors
comprises two groups: LPA receptors and sphingosine-1-
phosphate (S1P) receptors. LPA receptors consist of LPA1
(Edg-2/lpA1/vzg-1/rec1.3), LPA2 (Edg-4/lpA2) and LPA3
(Edg-7/lpA3), and S1P receptors include S1P1 (Edg-1/lpB1),
S1P2 (Edg-5/lpB2/AGR16/H218), S1P3 (Edg-3/lpB3), S1P4
(Edg-6/lpB4), and S1P5 (Edg-8/lpB5/nrg-1). Weiner and Chun
studied the expression of LPL receptors in Schwann cells
(SC) in vivo and in vitro using total RNA by Northern blot
analysis, and reported that LPA1 was expressed at high level
by SCs in vivo and in vitro, whereas S1P1 was only
expressed in SCs in vivo. Neither LPA2 nor S1P2 was detect-
able, although S1P3 was expressed in SCs in vivo and in vitro
[23]. On the contrary, we were unable to detect the expres-
sion of S1P1 in isolated MSCs. This difference might be
caused by the sampling method, because Weiner and Chun
recognized expression of S1P1 in vivo. Considering the fact
that MSCs and TSCs behave differently after nerve injury, it
would be worth studying changes of expression of each
member of LPL gene family after nerve injury. Those
studies are currently underway.
In conclusion, we studied the differential expression of
LPL receptor gene family in TSCs and MSCs at single cell-
based RT-PCR and found that LPA3 is specifically expressed
in TSCs as confirmed by in situ hybridization. This differen-
tial expression of LPL receptors in TSCs and MSCs may
underlie the behavior of each type of Schwann cells after
nerve injury.
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